Form 4 holding
Director
4D Molecular Therapeutics Inc.
- Security class
- Common Stock
- Shares / value
- 901,215
- Estimated value
- $16,589,476
- Report date
- 22 Oct 2021
- Price
- $18.41
- Ownership
- Direct
David Schaffer - Director at 4D Molecular Therapeutics, Inc.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- FDMT on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by David Schaffer since 30 Aug 2025
Reported holdings for David Schaffer in 4D Molecular Therapeutics, Inc.
Transaction history for David Schaffer in 4D Molecular Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.